{"id":10996,"date":"2019-08-09T16:49:30","date_gmt":"2019-08-09T16:49:30","guid":{"rendered":"http:\/\/drupal.test\/projects\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/"},"modified":"2022-07-26T13:15:19","modified_gmt":"2022-07-26T17:15:19","slug":"panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies","status":"publish","type":"project","link":"https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/","title":{"rendered":"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies"},"content":{"rendered":"<p>Au cours des deux ou trois derni\u00e8res ann\u00e9es, l\u2019Ontario Institute for Cancer Research (OICR) et Thermo Fisher Scientific (TFS) ont \u00e9tabli un partenariat afin de mettre au point des solutions g\u00e9nomiques con\u00e7ues pour \u00eatre adopt\u00e9es rapidement en clinique. La collaboration entre l\u2019OICR et TFS a donn\u00e9 lieu au lancement commercial du panel complet OncomineMC (v. 3). Le projet actuel est ax\u00e9 sur le d\u00e9veloppement de nouvelles signatures de biomarqueurs reposant sur le s\u00e9quen\u00e7age combin\u00e9 de l\u2019ARN et de l\u2019ADN et pr\u00e9sentant une utilit\u00e9 clinique chez des cohortes de patients bien caract\u00e9ris\u00e9es, et ce, dans le but de mettre au point des \u00e9preuves diagnostiques cliniques pour le cancer du pancr\u00e9as, de la prostate et du sein et de fournir un mod\u00e8le d\u2019adoption dans d\u2019autres contextes pathologiques.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Au cours des deux ou trois derni\u00e8res ann\u00e9es, l\u2019Ontario Institute for Cancer Research (OICR) et Thermo Fisher Scientific (TFS) ont \u00e9tabli un partenariat afin de mettre au point des solutions g\u00e9nomiques con\u00e7ues pour \u00eatre adopt\u00e9es rapidement en clinique. La collaboration entre l\u2019OICR et TFS a donn\u00e9 lieu au lancement commercial du panel complet OncomineMC (v. [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[92],"genome-competitions":[210],"project-sector":[],"genome_centres":[108],"class_list":["post-10996","project","type-project","status-publish","hentry","project-categories-translation-fr","genome-competitions-programme-de-partenariats-pour-les-applications-de-la-genomique","genome_centres-ontario-genomics-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Au cours des deux ou trois derni\u00e8res ann\u00e9es, l\u2019Ontario Institute for Cancer Research (OICR) et Thermo Fisher Scientific (TFS) ont \u00e9tabli un partenariat afin de mettre au point des solutions g\u00e9nomiques con\u00e7ues pour \u00eatre adopt\u00e9es rapidement en clinique. La collaboration entre l\u2019OICR et TFS a donn\u00e9 lieu au lancement commercial du panel complet OncomineMC (v. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T17:15:19+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\\\/\",\"name\":\"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2019-08-09T16:49:30+00:00\",\"dateModified\":\"2022-07-26T17:15:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/project\\\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/dev.genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/dev.genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies - GenomeCanada","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies - GenomeCanada","og_description":"Au cours des deux ou trois derni\u00e8res ann\u00e9es, l\u2019Ontario Institute for Cancer Research (OICR) et Thermo Fisher Scientific (TFS) ont \u00e9tabli un partenariat afin de mettre au point des solutions g\u00e9nomiques con\u00e7ues pour \u00eatre adopt\u00e9es rapidement en clinique. La collaboration entre l\u2019OICR et TFS a donn\u00e9 lieu au lancement commercial du panel complet OncomineMC (v. [&hellip;]","og_url":"https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T17:15:19+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/","url":"https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/","name":"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies - GenomeCanada","isPartOf":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#website"},"datePublished":"2019-08-09T16:49:30+00:00","dateModified":"2022-07-26T17:15:19+00:00","breadcrumb":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.genomecanada.ca\/fr\/project\/panels-de-sequencage-cibles-de-nouvelle-generation-pour-la-prise-en-charge-clinique-des-maladies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Panels de s\u00e9quen\u00e7age cibl\u00e9s de nouvelle g\u00e9n\u00e9ration pour la prise en charge clinique des maladies"}]},{"@type":"WebSite","@id":"https:\/\/dev.genomecanada.ca\/fr\/#website","url":"https:\/\/dev.genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/dev.genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/dev.genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/dev.genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/dev.genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10996\/revisions"}],"wp:attachment":[{"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10996"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10996"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10996"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10996"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/dev.genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}